OBJECTIVE: To determine whether asthma-specific quality of life during pregnancy is related to asthma exacerbations and to perinatal outcomes. METHODS: This was a secondary analysis of data from a randomized controlled trial of inhaled beclomethasone versus theophylline in the treatment of moderate asthma during pregnancy. The Juniper Asthma Quality of Life Questionnaire (AQLQ) was administered to patients at enrollment. Exacerbations were defined as asthma symptoms requiring a hospitalization, unscheduled medical visit, or oral corticosteroid course. RESULTS:Quality of life assessments were provided by 310 of the 385 participants who completed the study. There was more than a 25% decrease in the odds of a subsequent asthma exacerbation for every 1-point increase in AQLQ score for the overall score (odds ratio [OR] 0.73, 95% confidence interval [CI] 0.55-0.96), emotion domain (OR 0.72, 95% CI 0.59-0.88), and symptoms domain (OR 0.73, 95% CI 0.57-0.94). These relationships were not significantly influenced by initial symptom frequency or forced expiratory volume in 1 s (FEV(1)). No significant relationships were demonstrated between enrollment AQLQ scores and preeclampsia, preterm birth, low birth weight, or small for gestational age. CONCLUSION: Asthma-specific quality of life in early pregnancy is related to subsequent asthma morbidity during pregnancy but not to perinatal outcomes.
RCT Entities:
OBJECTIVE: To determine whether asthma-specific quality of life during pregnancy is related to asthma exacerbations and to perinatal outcomes. METHODS: This was a secondary analysis of data from a randomized controlled trial of inhaled beclomethasone versus theophylline in the treatment of moderate asthma during pregnancy. The JuniperAsthma Quality of Life Questionnaire (AQLQ) was administered to patients at enrollment. Exacerbations were defined as asthma symptoms requiring a hospitalization, unscheduled medical visit, or oral corticosteroid course. RESULTS: Quality of life assessments were provided by 310 of the 385 participants who completed the study. There was more than a 25% decrease in the odds of a subsequent asthma exacerbation for every 1-point increase in AQLQ score for the overall score (odds ratio [OR] 0.73, 95% confidence interval [CI] 0.55-0.96), emotion domain (OR 0.72, 95% CI 0.59-0.88), and symptoms domain (OR 0.73, 95% CI 0.57-0.94). These relationships were not significantly influenced by initial symptom frequency or forced expiratory volume in 1 s (FEV(1)). No significant relationships were demonstrated between enrollment AQLQ scores and preeclampsia, preterm birth, low birth weight, or small for gestational age. CONCLUSION:Asthma-specific quality of life in early pregnancy is related to subsequent asthma morbidity during pregnancy but not to perinatal outcomes.
Authors: Michael Schatz; David Mosen; Andrea J Apter; Robert S Zeiger; William M Vollmer; Thomas B Stibolt; Albin Leong; Michael S Johnson; Guillermo Mendoza; E Francis Cook Journal: J Allergy Clin Immunol Date: 2005-05 Impact factor: 10.793
Authors: Gregory B Diette; Jerry A Krishnan; Linda L Wolfenden; E Ann Skinner; Donald M Steinwachs; Albert W Wu Journal: Ann Allergy Asthma Immunol Date: 2004-12 Impact factor: 6.347
Authors: Michael Schatz; Mitchell P Dombrowski; Robert Wise; Valerija Momirova; Mark Landon; William Mabie; Roger B Newman; Dwight J Rouse; Marshall Lindheimer; Menachem Miodovnik; Steve N Caritis; Kenneth J Leveno; Paul Meis; Ronald J Wapner; Richard H Paul; Mary Jo O'Sullivan; Michael W Varner; Gary R Thurnau; Deborah L Conway Journal: Am J Obstet Gynecol Date: 2006-01 Impact factor: 8.661
Authors: Michael Schatz; David Mosen; Andrea J Apter; Robert S Zeiger; William M Vollmer; Thomas B Stibolt; Albin Leong; Michael S Johnson; Guillermo Mendoza; E Francis Cook Journal: J Allergy Clin Immunol Date: 2005-03 Impact factor: 10.793
Authors: Elizabeth W Triche; Audrey F Saftlas; Kathleen Belanger; Brian P Leaderer; Michael B Bracken Journal: Obstet Gynecol Date: 2004-09 Impact factor: 7.661
Authors: Emily Bain; Kristen L Pierides; Vicki L Clifton; Nicolette A Hodyl; Michael J Stark; Caroline A Crowther; Philippa Middleton Journal: Cochrane Database Syst Rev Date: 2014-10-21
Authors: István Ivancsó; Gergely Toldi; Anikó Bohács; Noémi Eszes; Veronika Müller; János Rigó; Barna Vásárhelyi; György Losonczy; Lilla Tamási Journal: PLoS One Date: 2013-04-02 Impact factor: 3.240
Authors: Noémi Eszes; Gergely Toldi; Anikó Bohács; István Ivancsó; Veronika Müller; János Rigó; György Losonczy; Barna Vásárhelyi; Lilla Tamási Journal: PLoS One Date: 2014-04-15 Impact factor: 3.240